(A3) Beating Cancer: Impact of APOBEC3B on 5-Fluorouracil Treatment

被引：0
|
作者：
Fine, Sydney R. [1 ]
机构：
[1] Coll Wooster, Biochem & Mol Biol, Wooster, OH 44691 USA
来源：
FASEB JOURNAL | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
775.9
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Involvement of APOBEC3B in mutation induction by irradiation
    Saito, Yohei
    Miura, Hiromasa
    Takahashi, Nozomi
    Kuwahara, Yoshikazu
    Yamamoto, Yumi
    Fukumoto, Manabu
    Yamamoto, Fumihiko
    JOURNAL OF RADIATION RESEARCH, 2020, 61 (06) : 819 - 827
  • [42] The cytidine deaminase APOBEC3B is a regulator of gene expression in breast cancer
    Periyasamy, Manikandan
    CANCER RESEARCH, 2017, 77
  • [43] Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes
    Ambrocio Sanchez
    Pedro Ortega
    Ramin Sakhtemani
    Lavanya Manjunath
    Sunwoo Oh
    Elodie Bournique
    Alexandrea Becker
    Kyumin Kim
    Cameron Durfee
    Nuri Alpay Temiz
    Xiaojiang S. Chen
    Reuben S. Harris
    Michael S. Lawrence
    Rémi Buisson
    Nature Communications, 15
  • [44] APOBEC3B expression in human leptomeninges and meningiomas
    Johnson, Mahlon D.
    Reeder, Jay E.
    O'Connell, Mary
    ONCOLOGY LETTERS, 2016, 12 (06) : 5344 - 5348
  • [45] Development of small molecule inhibitors of the breast cancer oncoprotein APOBEC3B
    Olson, Margaret E.
    Li, Ming
    Perkins, Angela L.
    Kempema, Aaron M.
    Harris, Reuben S.
    Harki, Daniel A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [46] Correction: Corrigendum: APOBEC3B is an enzymatic source of mutation in breast cancer
    Michael B. Burns
    Lela Lackey
    Michael A. Carpenter
    Anurag Rathore
    Allison M. Land
    Brandon Leonard
    Eric W. Refsland
    Delshanee Kotandeniya
    Natalia Tretyakova
    Jason B. Nikas
    Douglas Yee
    Nuri A. Temiz
    Duncan E. Donohue
    Rebecca M. McDougle
    William L. Brown
    Emily K. Law
    Reuben S. Harris
    Nature, 2013, 502 : 580 - 580
  • [47] Computational drug discovery of an inhibitor of APOBEC3B as a treatment for epithelial cancers
    Caputa, Dominic A.
    Blankenship, Quin P.
    Smith, Zachary D.
    Huebner, Molly M.
    Vetter, Zoe A.
    Parks, Richard W.
    Lobera, Saul Armendariz
    Leddin, Emmett M.
    Taylor, Cooper A.
    Parish, Carol A.
    Miller III, Bill R.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025, 43 (04): : 1955 - 1968
  • [48] Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes
    Sanchez, Ambrocio
    Ortega, Pedro
    Sakhtemani, Ramin
    Manjunath, Lavanya
    Oh, Sunwoo
    Bournique, Elodie
    Becker, Alexandrea
    Kim, Kyumin
    Durfee, Cameron
    Temiz, Nuri Alpay
    Chen, Xiaojiang S.
    Harris, Reuben S.
    Lawrence, Michael S.
    Buisson, Remi
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [49] DNA replication stress: a source of APOBEC3B expression in breast cancer
    David W. Cescon
    Benjamin Haibe-Kains
    Genome Biology, 17
  • [50] Progressive APOBEC3B mRNA expression in distant breast cancer metastases
    Sieuwerts, Anieta M.
    Schrijver, Willemijne A. M. E.
    Dalm, Simone U.
    de Weerd, Vanja
    Moelans, Cathy B.
    ter Hoeve, Natalie
    van Diest, Paul J.
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    PLOS ONE, 2017, 12 (01):
12345